TECHNOLOGY & INNOVATION
Our product development team uses innovative ideas and practices different novel technologies for the development of better product outcome.
- For the Oral drug delivery, our technologies concentrates on increasing thebioavailability of the drug, targeted, controlled and sustained release of the drugs that are being incorporated in our nutraceutical products. We mainly focus on the Bioavailability and Stability enhancements.
- Bioavailability enhancement Our technology uses a combination of granulation, extrusion and spheronization, using natural bio-availability enhancers which increases the percentage of absorption of extracts in the body. Bioavailability enhancement strategies include nano-delivery system, absorption enhancers and excipients food. Nanoparticle based formulation deliver to specific tissue and provide controlled release therapy and sustained release therapy to decrease the toxicity and increase patient compliance with less frequent dosing.
- Stability enhancement Stability enhancement of the products is achieved by improving the solubility, an important parameter for a stable product. Solubility improving method depends on the property of the drug, site of absorption, and required dosage form characteristics. This is executed by employing different techniques like nanoemulsion, microemulsion, high pressure homogenization and many other similar methods.
Permeation enhancement:-
Permeation enhancement, better release profile and site specific delivery in cosmeceutical products is achieved by incorporating different transdermal delivery techniques. The different technology includes particle size reduction, cosolvency, dispersion of the drug using a carrier. Some novel approaches like delivery by liposomes, niosomes and microemulsion, nanoemulsions, Solid Lipid Nanoparticles are also used in our formulations.
- For the Oral drug delivery, our technologies concentrates on increasing thebioavailability of the drug, targeted, controlled and sustained release of the drugs that are being incorporated in our nutraceutical products. We mainly focus on the Bioavailability and Stability enhancements.
- Bioavailability enhancement Our technology uses a combination of granulation, extrusion and spheronization, using natural bio-availability enhancers which increases the percentage of absorption of extracts in the body. Bioavailability enhancement strategies include nano-delivery system, absorption enhancers and excipients food. Nanoparticle based formulation deliver to specific tissue and provide controlled release therapy and sustained release therapy to decrease the toxicity and increase patient compliance with less frequent dosing.
- Stability enhancement Stability enhancement of the products is achieved by improving the solubility, an important parameter for a stable product. Solubility improving method depends on the property of the drug, site of absorption, and required dosage form characteristics. This is executed by employing different techniques like nanoemulsion, microemulsion, high pressure homogenization and many other similar methods.
Permeation enhancement:-
Permeation enhancement, better release profile and site specific delivery in cosmeceutical products is achieved by incorporating different transdermal delivery techniques. The different technology includes particle size reduction, cosolvency, dispersion of the drug using a carrier. Some novel approaches like delivery by liposomes, niosomes and microemulsion, nanoemulsions, Solid Lipid Nanoparticles are also used in our formulations.
ORAL
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
THERAPEUTIC AREAS
Our work spans 6 discrete therapeutic areas within which we master the techniques of nurturing an idea to fruitful completion in the form of a product. Click on the areas below to read more about the work we’ve done
DELIVERY PLATFORMS
- Increased bioavailability
- Increased efficacy
- Targeted delivery
- Decreased toxicity/side effects
- Increased convenience
- Potential for prophylactic applications
- Better patient compliance
- Achieve targeting
- Controlled release
- Sustained release
- Increased permeation
- Better bioavailabilty
- Better release profile
- Site specific delivery
- Decreased toxicity/side effects
- Increased convenience
- Better patient compliance
- Sustained release
- Controlled release
- Novel delivery systems like patches, films etc.
- Transdermals – Gels, Creams, Ointments, Lotions
- Nanocrystals
- Lipid-based nanoparticles like NLC, SLN, LBC
- Nano lipid carriers
- Solid lipid nanoparticle
- Lipid drug conjugate
- SNEDDS- Self emulsifying nano drug delivery system
- Transdermal patches
- Mouth Dissolving Films
- Sterile Liquids – Solutions, Suspensions, Colloids, Liposomes
- Powders – Sterile and non-sterile powder filling
- Sterile liquid dosage formulations (ophthalmic, oral, nasal)
- Injectable drugs (intravenous, and intramuscular, subcutaneous injectables)
DOSAGE FORMATS
ORAL DELIVERY
Previous
Next
ORAL DELIVERY
Previous
Next
Identification of therapeutic area
Althea to suggest ingredient composition
Rational and Intelligent selection of actives
Procurement of high quality ingredients from qualified vendors
Development of preformulation
Characterization of different actives
Efficacy screening using relevant In Vitro cell based models
Identification of hits
Preclinical efficacy testing through specialized In Vitro and In Vivo models
0%
Innovation
100%
Identification of therapeutic area
Althea to suggest ingredient composition
Rational and Intelligent selection of actives
Procurement of high quality ingredients from qualified vendors
Development of preformulation
Characterization of different actives
Efficacy screening using relevant In Vitro cell based models
Identification of hits
Preclinical efficacy testing through specialized In Vitro and In Vivo models
